Bank of Montreal’s Co-Diagnostics CODX Stock Holding History

Bank of Montreal’s Portfolio CODX Stock Details CODX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q1	–	Sell	-890	Closed	-$279K	–	5101
2020 Q4	$279K	Buy	+890	New	+$330K	﹤0.01%	3034

Other funds holding CODX

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

BCM

Bridgeway Capital Management Houston, Texas $4.97B AUM 44.96% 1-Year Est. Return

KAS

Kestra Advisory Services Austin, Texas $31B AUM 28.39% 1-Year Est. Return

Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return

Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

Bank of Montreal's CODX Position: Q1 2024 in Review

Bank of Montreal sold out of Co-Diagnostics (CODX) in Q1 2024, closing a stake of 2,497 shares — an estimated $118K sold.

Bank of Montreal first reported a position in CODX in Q1 2019 and held it in 9 quarters. The position peaked at $319K in Q4 2020. 38 funds tracked by Wall St. Rank hold CODX as of Q1 2024.

Bank of Montreal reported no remaining Co-Diagnostics position as of Q1 2024 after selling out during the quarter.
Bank of Montreal sold 2,497 Co-Diagnostics shares in Q1 2024, an estimated $118K.
Bank of Montreal first reported a position in Co-Diagnostics in Q1 2019 and held it in 9 quarters.
Bank of Montreal's Co-Diagnostics position peaked at $319K in Q4 2020.
38 funds tracked by Wall St. Rank held Co-Diagnostics as of Q1 2024.

Based on Bank of Montreal's 13F filing for Q1 2024, filed 13 May 2024.